The global Esoteric Testing Market is valued at USD 30.56 billion in 2024 and is projected to reach a value of USD 84.12 ...

Medtronic receives CE Mark for VitalFlow™ ECMO System, ushering in a new era of critical care in EuropeMedtronic expands its cardiac surgical and respiratory innovation portfolio with the launch of ...

Transplants can be life-saving – but for many, the journey doesn’t end there. Up to 40% of people receiving a stem cell or bone marrow transplant will go on to develop a serious complication known as ...

Novo Nordisk invests €2.34B to expand its Anagni facility near Rome, enhancing production of diabetes and obesity treatments ...

Merck (MSD outside US & Canada) announces $10B acquisition of Verona Pharma to enhance its respiratory portfolio with COPD ...

COLDWATER, MICHIGAN / ACCESS Newswire / July 9, 2025 / Emergency Care Partners (ECP), a leading national emergency medicine services group, announced today the addition of INSIGHT Hospital and Medical ...

Black Book Flash Poll Reveals Serious Concerns About Workforce Instability and Care Disruptions Across Hospitals, Nursing Homes, and Long-Term Care Facilities NEW YORK CITY, NEW YORK / ACCESS Newswire ...

Winner of the DEXIS IS 3800W Intraoral Scanner to Be Revealed This August QUAKERTOWN, PENNSYLVANIA / ACCESS Newswire / July 9, 2025 / DEXIS™, a global leader in dental imaging innovation, announces ...

Skip the Clinic - New Mobile Wound Care Service Offers Cutting-Edge Treatment at Home GREENVILLE, SOUTH CAROLINA / ACCESS Newswire / July 9, 2025 / Patients across Upstate and Midlands of South ...

MESA, ARIZONA / ACCESS Newswire / July 9, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) is advancing a powerful multi-sector strategy focused on three explosive industries: AI-powered digital ...

HOUSTON, TX / ACCESS Newswire / July 9, 2025 / Mann Eye Institute, a leader in innovative eye care since the 1970s, is proud to announce the addition of the LumiThera Valeda Light Delivery System to ...

HOUSTON, TX / ACCESS Newswire / July 9, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ...